Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Volume 17, Issue 9, October 2020 - First Report Managed Care

Featured Article

10/23/2020

Mary Beth Nierengarten

Mary Beth Nierengarten
Recent strains on primary care, including the COVID-19 pandemic, have inspired many practicing clinicians, administrators, and payers to examine its sustainability, reimbursement, and develop solutions to save practices.
Recent strains on primary care, including the COVID-19 pandemic, have inspired many practicing clinicians, administrators, and payers to examine its sustainability, reimbursement, and develop solutions to save practices.
Recent strains on primary care,...
10/23/2020
First Report Managed Care
10/23/2020

Dean Celia

Dean Celia
The Supreme Court is scheduled to hear arguments on November 10 in California v Texas, and render a decision early next year that will determine the future of the ACA. What are the potential outcomes, and how should payers prepare for each?...
The Supreme Court is scheduled to hear arguments on November 10 in California v Texas, and render a decision early next year that will determine the future of the ACA. What are the potential outcomes, and how should payers prepare for each?...
The Supreme Court is scheduled...
10/23/2020
First Report Managed Care
10/16/2020

Paul Nicolaus

Paul Nicolaus
Researchers reveal that universal screening for the total United States adult population is not cost-effective, according to their recent analysis, but focusing on people who inject drugs could be.
Researchers reveal that universal screening for the total United States adult population is not cost-effective, according to their recent analysis, but focusing on people who inject drugs could be.
Researchers reveal that...
10/16/2020
First Report Managed Care

Department

Formulary Frontlines®
10/15/2020

Edan Stanley

Edan Stanley
Although it is rarer than most, multiple myeloma is the second most common blood cancer after non-Hodgkin lymphoma—effecting more than 130,000 adults in the United States.
Although it is rarer than most, multiple myeloma is the second most common blood cancer after non-Hodgkin lymphoma—effecting more than 130,000 adults in the United States.
Although it is rarer than most,...
10/15/2020
First Report Managed Care

Advertisement

Advertisement

Advertisement